SCHEDULE 13G/A 0001493152-24-033701 0001754540 XXXXXXXX LIVE 2 Common Stock, $0.001 Par Value 08/06/2025 0001534120 Avalo Therapeutics, Inc. 05338F306 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087 Rule 13d-1(c) Patrick J. Crutcher X1 549467.00 0.00 549467.00 0.00 549467.00 N 4.2 IN See Item 2 for additional information. Avalo Therapeutics, Inc. 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087 This report on Schedule 13G is being filed by Patrick J. Crutcher (the "Reporting Person"). The ownership percentages are based upon 13,152,356 shares of Common Stock outstanding as disclosed in the Issuer's final prospectus filed with the with SEC on August 7, 2025. The address for the Reporting Person is: 650 Ponce De Leon Ave., Suite 300 #2347, Atlanta, GA 30308. USA Y 549,467.00 4.2 549,467.00 0 549,467.00 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Patrick J. Crutcher /s/ Patrick J. Crutcher 08/27/2025